MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank67
3Y CAGR+17.4%
5Y CAGR+29.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+17.4%/yr
Annual compound
5Y CAGR
+29.0%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $197051.00 | -8.5% |
| 2024 | $215437.00 | +5.3% |
| 2023 | $204617.00 | +68.1% |
| 2022 | $121749.00 | +56.2% |
| 2021 | $77960.00 | +41.6% |
| 2020 | $55060.00 | - |
| 2019 | $0.00 | - |